Andreas Ranft
Overview
Explore the profile of Andreas Ranft including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1285
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stork T, Ranft A, Aigner C, Jurgens H, Ladenstein R, Timmermann B, et al.
Cancers (Basel)
. 2025 Jan;
17(1.
PMID: 39796745
Objective: Ewing sarcoma (EWS) of the mediastinum is extremely rare, with only a few cases reported in the literature. We aimed to gain a better understanding of primary mediastinal EWS,...
2.
Zimmermann J, Sorg C, Muller L, Zistler F, Neumaier V, Bonhoeffer M, et al.
Anesthesiology
. 2025 Jan;
142(4):692-703.
PMID: 39786916
Background: According to the model of the glymphatic system, the directed flow of cerebrospinal fluid (CSF) is a driver of waste clearance from the brain. In sleep, glymphatic transport is...
3.
Ranft A, Berger S, Schubert M, Wunderlich S, Boeckh-Behrens T, Schneider G, et al.
J Clin Anesth
. 2024 Oct;
99:111665.
PMID: 39471529
Study Objective: Blood pressure drops during endovascular treatment of acute ischemic stroke have been associated with worse outcomes for stroke patients. We aimed to evaluate this observation in our patient...
4.
Choderlos de Laclos X, Risbourg S, Brennan B, Bertucci F, Gaspar N, Gelderblom H, et al.
Eur J Cancer
. 2024 Jul;
208:114229.
PMID: 39032218
Introduction: Ewing sarcoma (ES), is a rare cancer affecting children, adolescents and adults. After VIDE (vincristine-ifosfamide-doxorobucin-etoposide) induction chemotherapy, Busulfan-Melphalan (BuMel) high-dose chemotherapy followed by autologous hematopoietic stem cells transplantation improved...
5.
van der Perk M, Broer L, Yasui Y, Laven J, Robison L, Tissing W, et al.
Fertil Steril
. 2024 May;
122(3):514-524.
PMID: 38729340
Objective: To discover new variants associated with low ovarian reserve after gonadotoxic treatment among adult female childhood cancer survivors using a genome-wide association study approach. Design: Genome-wide association study. Setting:...
6.
Rechl V, Ranft A, Bhadri V, Brichard B, Collaud S, Cyprova S, et al.
Sarcoma
. 2024 Mar;
2024:4751914.
PMID: 38524902
Background: Ewing sarcoma (EwS) is a rare and highly malignant bone tumor primarily affecting children, adolescents, and young adults. The pelvis, trunk, and lower extremities are the most common sites,...
7.
Castrillon G, Epp S, Bose A, Fraticelli L, Hechler A, Belenya R, et al.
Sci Adv
. 2023 Dec;
9(50):eadi7632.
PMID: 38091393
In comparison to other species, the human brain exhibits one of the highest energy demands relative to body metabolism. It remains unclear whether this heightened energy demand uniformly supports an...
8.
Luppi A, Golkowski D, Ranft A, Ilg R, Jordan D, Bzdok D, et al.
bioRxiv
. 2023 Nov;
PMID: 38014199
The human brain is characterised by idiosyncratic patterns of spontaneous thought, rendering each brain uniquely identifiable from its neural activity. However, deep general anaesthesia suppresses subjective experience. Does it also...
9.
Koch R, Haveman L, Ladenstein R, Brichard B, Jurgens H, Cyprova S, et al.
Clin Cancer Res
. 2023 Oct;
29(24):5057-5068.
PMID: 37843857
Purpose: The phase III, open-label, prospective, multicenter, randomized Ewing 2008R1 trial (EudraCT2008-003658-13) was conducted in 12 countries to evaluate the effect of zoledronic acid (ZOL) maintenance therapy compared with no...
10.
Heesen P, Ranft A, Bhadri V, Brichard B, Collaud S, Cyprova S, et al.
Eur J Cancer
. 2023 Aug;
192:113260.
PMID: 37595489
Background: Local treatment is a crucial element in the standard of care for Ewing sarcoma (EWS). While systemic treatment is improved in randomised clinical trials, local treatment modalities are discussed...